Osimertinib vs Ranitidine
Osimertinib vs Ranitidine: Overview
This comparison examines the pharmacological differences between Osimertinib and Ranitidine.
Mechanism of Action
Osimertinib: Third-generation irreversible EGFR TKI targeting T790M resistance mutation and activating mutations.
Ranitidine: Competitive H2 receptor antagonist.
Pharmacokinetics
Half-life: Osimertinib β 48 hours; Ranitidine β 2-3 hours.
Chemical Properties
Molecular Formula: Osimertinib β C28H33N7O2; Ranitidine β C13H22N4O3S.
Molecular Weight: Osimertinib β 499.6050 g/mol; Ranitidine β 314.4050 g/mol.
Type: Osimertinib β Small molecule; Ranitidine β Small molecule.